Khubchandani; Czuczman, MS; Hernandez-Ilizaliturri, FJ (2009). "Dacetuzumab, a humanized mAb against CD40 for the treatment of hematological malignancies". Current opinion in investigational drugs (London, England : 2000). 10 (6): 579–87. PMID 19513947.